138 related articles for article (PubMed ID: 17530237)
1. Perfusion-sensitive MRI of pilocytic astrocytomas: initial results.
Grand SD; Kremer S; Tropres IM; Hoffmann DM; Chabardes SJ; Lefournier V; Berger FR; Pasteris C; Krainik A; Pasquier BM; Peoch M; Le Bas JF
Neuroradiology; 2007 Jul; 49(7):545-50. PubMed ID: 17530237
[TBL] [Abstract][Full Text] [Related]
2. [Perfusion magnetic resonance imaging for high grade astrocytomas: Can cerebral blood volume, peak height, and percentage of signal intensity recovery distinguish between progression and pseudoprogression?].
Martínez-Martínez A; Martínez-Bosch J
Radiologia; 2014; 56(1):35-43. PubMed ID: 23790618
[TBL] [Abstract][Full Text] [Related]
3. [Value of perfusion MRI in the study of pilocytic astrocytoma and hemangioblastoma: preliminary findings].
Bing F; Kremer S; Lamalle L; Chabardes S; Ashraf A; Pasquier B; Le Bas JF; Krainik A; Grand S
J Neuroradiol; 2009 May; 36(2):82-7. PubMed ID: 18930545
[TBL] [Abstract][Full Text] [Related]
4. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.
Calli C; Kitis O; Yunten N; Yurtseven T; Islekel S; Akalin T
Eur J Radiol; 2006 Jun; 58(3):394-403. PubMed ID: 16527438
[TBL] [Abstract][Full Text] [Related]
5. Radiation-induced regional cerebral blood volume (rCBV) changes in normal brain and low-grade astrocytomas: quantification and time and dose-dependent occurrence.
Fuss M; Wenz F; Scholdei R; Essig M; Debus J; Knopp MV; Wannenmacher M
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):53-8. PubMed ID: 10924971
[TBL] [Abstract][Full Text] [Related]
6. Correlation of relative permeability and relative cerebral blood volume in high-grade cerebral neoplasms.
Provenzale JM; York G; Moya MG; Parks L; Choma M; Kealey S; Cole P; Serajuddin H
AJR Am J Roentgenol; 2006 Oct; 187(4):1036-42. PubMed ID: 16985154
[TBL] [Abstract][Full Text] [Related]
7. Combined value of susceptibility-weighted and perfusion-weighted imaging in assessing who grade for brain astrocytomas.
Wang XC; Zhang H; Tan Y; Qin JB; Wu XF; Wang L; Zhang L
J Magn Reson Imaging; 2014 Jun; 39(6):1569-74. PubMed ID: 24987755
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of cerebral tumors using multi-section echo planar MR perfusion imaging.
Preul C; Kühn B; Lang EW; Mehdorn HM; Heller M; Link J
Eur J Radiol; 2003 Dec; 48(3):244-51. PubMed ID: 14652141
[TBL] [Abstract][Full Text] [Related]
9. Comparison of first-pass and second-bolus dynamic susceptibility perfusion MRI in brain tumors.
Spampinato MV; Wooten C; Dorlon M; Besenski N; Rumboldt Z
Neuroradiology; 2006 Dec; 48(12):867-74. PubMed ID: 17013587
[TBL] [Abstract][Full Text] [Related]
10. Role of Dynamic Contrast-Enhanced Perfusion Magnetic Resonance Imaging in Grading of Pediatric Brain Tumors on 3T.
Gupta PK; Saini J; Sahoo P; Patir R; Ahlawat S; Beniwal M; Thennarasu K; Santosh V; Gupta RK
Pediatr Neurosurg; 2017; 52(5):298-305. PubMed ID: 28848203
[TBL] [Abstract][Full Text] [Related]
11. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
Thomsen H; Steffensen E; Larsson EM
Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021
[TBL] [Abstract][Full Text] [Related]
12. Relative cerebral blood volume from dynamic susceptibility contrast perfusion in the grading of pediatric primary brain tumors.
Ho CY; Cardinal JS; Kamer AP; Kralik SF
Neuroradiology; 2015 Mar; 57(3):299-306. PubMed ID: 25504266
[TBL] [Abstract][Full Text] [Related]
13. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging.
Knopp EA; Cha S; Johnson G; Mazumdar A; Golfinos JG; Zagzag D; Miller DC; Kelly PJ; Kricheff II
Radiology; 1999 Jun; 211(3):791-8. PubMed ID: 10352608
[TBL] [Abstract][Full Text] [Related]
14. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging.
Hakyemez B; Erdogan C; Ercan I; Ergin N; Uysal S; Atahan S
Clin Radiol; 2005 Apr; 60(4):493-502. PubMed ID: 15767107
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors.
Rollin N; Guyotat J; Streichenberger N; Honnorat J; Tran Minh VA; Cotton F
Neuroradiology; 2006 Mar; 48(3):150-9. PubMed ID: 16470375
[TBL] [Abstract][Full Text] [Related]
16. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas.
Law M; Oh S; Johnson G; Babb JS; Zagzag D; Golfinos J; Kelly PJ
Neurosurgery; 2006 Jun; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889
[TBL] [Abstract][Full Text] [Related]
17. Perfusion MR imaging in gliomas: comparison with histologic tumor grade.
Lee SJ; Kim JH; Kim YM; Lee GK; Lee EJ; Park IS; Jung JM; Kang KH; Shin T
Korean J Radiol; 2001; 2(1):1-7. PubMed ID: 11752962
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of hemangioblastomas from pilocytic astrocytomas using 3-T magnetic resonance perfusion-weighted imaging and MR spectroscopy.
She DJ; Xing Z; Zeng Z; Shang XY; Cao DR
Neuroradiology; 2015 Mar; 57(3):275-81. PubMed ID: 25487356
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the mismatched manifestation between rCBF and rCBV maps in cerebral astrocytomas.
Hu CH; Fang XM; Hu XY; Cui L
Clin Imaging; 2009; 33(6):417-23. PubMed ID: 19857800
[TBL] [Abstract][Full Text] [Related]
20. Effect of radiation on blood volume in low-grade astrocytomas and normal brain tissue: quantification with dynamic susceptibility contrast MR imaging.
Wenz F; Rempp K; Hess T; Debus J; Brix G; Engenhart R; Knopp MV; van Kaick G; Wannenmacher M
AJR Am J Roentgenol; 1996 Jan; 166(1):187-93. PubMed ID: 8571873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
